Nurix Therapeutics Investor Conference Participation
Analysis based on 6 articles · First reported Sep 01, 2026 · Last updated Sep 01, 2026
The announcement is a routine investor relations activity with minimal direct market impact. It may provide a platform for Nurix to communicate pipeline updates and potentially influence investor sentiment in the short term.
Nurix Therapeutics, Inc. announced that its management will participate in fireside chats at four upcoming investor conferences in September 2026: the Wells Fargo Healthcare Conference on September 8, the H.C. Wainwright Healthcare Conference on September 14, the Baird Healthcare Conference on September 15, and the Morgan Stanley Healthcare Conference on September 16. The fireside chats will be webcast live and archived on the company's website for 30 days. Nurix is a clinical-stage biopharmaceutical company focused on targeted protein degradation medicines for cancer and autoimmune diseases. Its pipeline includes collaborations with Roche, Gilead Sciences, Sanofi, and Pfizer.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard